Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, and the Middle East. Insulet Corporation was founded in 2000 and is headquartered in Acton, Massachusetts.
Latest shares articles
GBP drops as BOE vote split seems dovish
The BOE has left rates unchanged in December but a more dovish vote split has weighed on the pound.
13:15, 19 December 2024
A hawkish Fed cut sparks fresh volatility
Discover how the Federal Reserve's hawkish stance, revised SEP, and delayed inflation targets triggered market volatility, with stocks tumbling, bond yields surging, and a stronger US Dollar reshaping investor outlooks.
12:46, 19 December 2024
Gold Latest: XAU/USD stuck within range ahead of the FOMC meeting
Gold traders await the FOMC meeting to determine how many rate cuts to expect in 2025.
11:25, 18 December 2024
GBP/USD in focus ahead of FED and BOE meetings
Both the Federal Reserve and Bank of England will deliver their updated monetary policies this week, with GBP/USD likely to experience increased momentum.
17:33, 17 December 2024
Ratings and Reviews
Ratings and Reviews
